JP2017516459A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516459A5
JP2017516459A5 JP2016558605A JP2016558605A JP2017516459A5 JP 2017516459 A5 JP2017516459 A5 JP 2017516459A5 JP 2016558605 A JP2016558605 A JP 2016558605A JP 2016558605 A JP2016558605 A JP 2016558605A JP 2017516459 A5 JP2017516459 A5 JP 2017516459A5
Authority
JP
Japan
Prior art keywords
poloxamer
heated
minutes
cell culture
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016558605A
Other languages
English (en)
Japanese (ja)
Other versions
JP6655548B2 (ja
JP2017516459A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/022592 external-priority patent/WO2015148736A1/en
Publication of JP2017516459A publication Critical patent/JP2017516459A/ja
Publication of JP2017516459A5 publication Critical patent/JP2017516459A5/ja
Application granted granted Critical
Publication of JP6655548B2 publication Critical patent/JP6655548B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016558605A 2014-03-25 2015-03-25 細胞培養培地における使用のためのポロキサマーを調製する方法 Active JP6655548B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461970281P 2014-03-25 2014-03-25
US61/970,281 2014-03-25
PCT/US2015/022592 WO2015148736A1 (en) 2014-03-25 2015-03-25 Methods of preparing a poloxamer for use in cell culture medium

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020017136A Division JP2020103290A (ja) 2014-03-25 2020-02-04 細胞培養培地における使用のためのポロキサマーを調製する方法

Publications (3)

Publication Number Publication Date
JP2017516459A JP2017516459A (ja) 2017-06-22
JP2017516459A5 true JP2017516459A5 (cg-RX-API-DMAC7.html) 2018-05-10
JP6655548B2 JP6655548B2 (ja) 2020-02-26

Family

ID=52824596

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016558605A Active JP6655548B2 (ja) 2014-03-25 2015-03-25 細胞培養培地における使用のためのポロキサマーを調製する方法
JP2020017136A Withdrawn JP2020103290A (ja) 2014-03-25 2020-02-04 細胞培養培地における使用のためのポロキサマーを調製する方法
JP2022157928A Active JP7472222B2 (ja) 2014-03-25 2022-09-30 細胞培養培地における使用のためのポロキサマーを調製する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020017136A Withdrawn JP2020103290A (ja) 2014-03-25 2020-02-04 細胞培養培地における使用のためのポロキサマーを調製する方法
JP2022157928A Active JP7472222B2 (ja) 2014-03-25 2022-09-30 細胞培養培地における使用のためのポロキサマーを調製する方法

Country Status (19)

Country Link
US (2) US11034793B2 (cg-RX-API-DMAC7.html)
EP (2) EP3122799B8 (cg-RX-API-DMAC7.html)
JP (3) JP6655548B2 (cg-RX-API-DMAC7.html)
KR (1) KR102352250B1 (cg-RX-API-DMAC7.html)
CN (2) CN106414552B (cg-RX-API-DMAC7.html)
AU (1) AU2015236008B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016021739B1 (cg-RX-API-DMAC7.html)
CA (1) CA2943357C (cg-RX-API-DMAC7.html)
ES (1) ES2778680T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200372T1 (cg-RX-API-DMAC7.html)
IL (2) IL247902B (cg-RX-API-DMAC7.html)
MX (2) MX2016012288A (cg-RX-API-DMAC7.html)
MY (1) MY178060A (cg-RX-API-DMAC7.html)
PL (1) PL3122799T3 (cg-RX-API-DMAC7.html)
RU (1) RU2710551C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201607929PA (cg-RX-API-DMAC7.html)
SI (1) SI3122799T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015148736A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201606711B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3122799B8 (en) 2014-03-25 2020-03-11 F.Hoffmann-La Roche Ag Methods of preparing a poloxamer for use in cell culture medium
WO2017157505A1 (en) 2016-03-17 2017-09-21 Merck Patent Gmbh Method for purifying poloxamers
SG11202002351SA (en) * 2017-12-21 2020-07-29 Sigma Aldrich Co Llc Poloxamer compositions and methods of making and using same
WO2020013725A1 (en) * 2018-07-12 2020-01-16 Arshintseva Elena Valentinovna Thermal method for sterilizing poloxamer comprising liquid drugs
KR102853452B1 (ko) * 2018-07-27 2025-09-03 아지노모토 가부시키가이샤 동물 세포의 부유 배양용 첨가물, 부유 배양용 배지 및 부유 배양 방법

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (cg-RX-API-DMAC7.html)
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
AU2699892A (en) 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
DK0754050T3 (da) 1994-01-14 2002-10-21 Xoma Technology Ltd Anti-gram-positive bakterielle fremgangsmåder og materialer
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
ES2248127T3 (es) 1999-10-04 2006-03-16 Medicago Inc. Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno.
TWI367113B (en) * 2003-02-12 2012-07-01 Syncera Inc Random and non-random alkylene oxide polymer alloy compositions
US8802116B2 (en) * 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
EP1660227B1 (en) * 2003-08-04 2012-05-23 Camurus Ab Method for improving the properties of amphiphile particles
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20060121016A1 (en) 2004-10-18 2006-06-08 Lee Raphael C Methods and compositions for treatment of free radical injury
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
CN1939534B (zh) 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
CN101516339B (zh) 2006-08-16 2012-06-13 诺瓦提斯公司 制备高度结晶的治疗化合物的固体分散体的方法
KR100932613B1 (ko) 2007-04-27 2009-12-17 한남대학교 산학협력단 고분자 용융공정을 이용한 약물전달용 생체적합성 고분자나노 미립구의 제조방법 및 그 나노 미립구
WO2009055312A1 (en) * 2007-10-22 2009-04-30 Dfb Pharmaceuticals, Inc. Process for producing a poloxamer gel
PT2574677T (pt) 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células
BR112012015596B1 (pt) * 2009-12-23 2021-06-01 Sanofi Pasteur Processo de cultura de células aderentes
EP2830598B1 (en) * 2012-03-30 2016-11-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Microsphere compositions, preparation method and applications thereof
EP3122799B8 (en) 2014-03-25 2020-03-11 F.Hoffmann-La Roche Ag Methods of preparing a poloxamer for use in cell culture medium

Similar Documents

Publication Publication Date Title
JP2017516459A5 (cg-RX-API-DMAC7.html)
CN102532548B (zh) 一种耐低温硅橡胶生胶
CN101781085B (zh) 钢化、半钢化真空玻璃的制造方法
JP2013148806A5 (cg-RX-API-DMAC7.html)
JP2017516900A5 (cg-RX-API-DMAC7.html)
JP2017525650A5 (cg-RX-API-DMAC7.html)
JP2016507449A5 (cg-RX-API-DMAC7.html)
JP2012526622A5 (cg-RX-API-DMAC7.html)
HRP20200372T1 (hr) Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu
JP2016536391A5 (cg-RX-API-DMAC7.html)
JP2018520264A5 (cg-RX-API-DMAC7.html)
JP2016104558A5 (cg-RX-API-DMAC7.html)
TW201504171A (zh) 玻璃處理方法
CN110509578B (zh) 一种提高3d打印聚醚醚酮形状记忆性能的热处理方法
CN104163567A (zh) 钢化玻璃的生产方法
JP2018513093A5 (cg-RX-API-DMAC7.html)
CN107459745A (zh) 一种促进聚偏氟乙烯α晶型向γ晶型转变的方法
JP2021502943A5 (cg-RX-API-DMAC7.html)
CN108486337A (zh) 一种G18CrMo2-6钢的热处理工艺
CN106435835A (zh) 一种用于高温炉辊耐火纤维的制备方法
JP2010100701A5 (cg-RX-API-DMAC7.html)
CN104726805B (zh) 一种镁合金板材成形方法
CN103819690A (zh) 降解消除法制备高结晶度聚乳酸的工艺
CN104974362A (zh) 一种聚酰亚胺薄膜的制备工艺
CN102515490B (zh) 一种石英摆片的稳定化处理工艺